Rtw Investments, LP Alkermes Plc. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Rtw Investments, LP holds 7,557,835 shares of ALKS stock, worth $255 Million. This represents 3.55% of its overall portfolio holdings.
Number of Shares
7,557,835
Previous 6,654,033
13.58%
Holding current value
$255 Million
Previous $186 Million
16.71%
% of portfolio
3.55%
Previous 2.97%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$981 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$623 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$413 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$297 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.48MShares$185 Million0.25% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.53B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...